États-Unis · Magazines éco · Institutional Investor

Biopharma’s Sickly September

Publié par Institutional Investor · États-Unis il y a 5 j

September was a rough month for prominent biopharma and life sciences hedge funds.Many lost money, some by double-digit percentage rates. As a result, quite a few funds are up…

Lire l'article complet sur Institutional Investor Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.institutionalinvestor.com)

Biopharma’s Sickly September

À lire aussi

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else

Biopharma’s Sickly September

Partager

À lire aussi

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else